AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 2%
#61 out of 5084 analysts
Average Return
+17.44%
Win Rate
54%201 out of 375
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +329.62% | $2.60 | $11.17 | 2024-12-03 - 2025-10-30 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-05 - 2024-11-05 | Buy |
Trevi Therapeutics IncTRVI | +283.85% | $2.91 | $11.17 | 2024-11-07 - 2025-10-30 | Buy |
Cormedix IncCRMD | +230.33% | $3.33 | $11.00 | 2023-11-14 - 2024-11-14 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 23 | Buy | $30.00 | +20.39% | Maintains | 3 days ago |
Collegium Pharmaceutical IncCOLL | 22 | Buy | $46.00 | +29.03% | Reiterates | 4 days ago |
Amphastar Pharmaceuticals IncAMPH | 2 | Buy | $36.00 | +45.99% | Reiterates | 10 days ago |
Biocryst Pharmaceuticals IncBCRX | 17 | Buy | $20.00 | +175.86% | Maintains | 17 days ago |
Ocular Therapeutix IncOCUL | 5 | Buy | $20.00 | +69.20% | Maintains | a month ago |
Moonlake ImmunotherapeuticsMLTX | 13 | Buy | $20.00 | +103.87% | Maintains | a month ago |
Kalvista Pharmaceuticals IncKALV | 19 | Buy | $28.00 | +155.24% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 24 | Buy | $72.00 | +15.66% | Reiterates | 2 months ago |
Oculis Holding AgOCS | 1 | Buy | $36.00 | +79.19% | Initiates Coverage On | 2 months ago |
Liquidia CorpLQDA | 32 | Buy | $36.00 | +55.17% | Maintains | 3 months ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +163.16% | Maintains | 3 months ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +96.96% | Maintains | 3 months ago |
Viridian Therapeutics IncVRDN | 18 | Buy | $34.00 | +43.70% | Maintains | 3 months ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +227.38% | Downgrades | 3 months ago |
Clearside Biomedical IncCLSD | 16 | Hold | $45.00 | +1,093.63% | Downgrades | 3 months ago |
Cormedix IncCRMD | 18 | Buy | $20.00 | +72.12% | Maintains | 4 months ago |
Newamsterdam Pharma Co NvNAMS | 9 | Buy | $40.00 | +3.31% | Reiterates | 5 months ago |
Xenon Pharmaceuticals IncXENE | 12 | Buy | $55.00 | +28.90% | Maintains | 6 months ago |
Pacira Biosciences IncPCRX | 27 | Buy | $30.00 | +41.04% | Maintains | 6 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +40.85% | Maintains | 6 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | N/A | Downgrades | a year ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | a year ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 3 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.